Spero Therapeutics Announces Third Quarter 2024 Operating Results and Provides a Business Update
Phase 3 PIVOT-PO trial of tebipenem HBr remains on track to complete enrollment in 2H 2025Reiterate cash runway into mid-2026; Q3 2024 ending ...
usace.army.mil44m
Maj. Gen. Lalor encourages hope, connection at TACOM-wide suicide awareness event
Maj. Gen. Michael B. Lalor spoke about finding purpose, making connections and having hope at a TACOM suicide prevention ...